Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...
Hyperke Growth Partners has released detailed case study results demonstrating how direct-to-consumer brands can secure hundreds of retail placement opportunities through systematic outreach to ...
Google's Gemini is set to roll out a presentation creation feature, allowing users to generate presentations from documents ...
CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival ...
A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...
WKBN Youngstown on MSN
‘State of Science’ study on East Palestine complete
In the months and years after East Palestine’s train derailment, researchers from five universities started studies on the environmental and health effects. Those researchers presented their ...
The influence of external proof is important — but lasting impact comes from building it inside your organization.
Daily Times(PK) on MSN
World Bank annual meeting in Washington: Pakistan showcases FBR’s successful tax transformation
In his presentation, the Chairman FBR showcased Pakistan’s remarkable achievement in enhancing the tax-to-GDP ratio from 8.83 percent in FY 2023–24 to 10.33 percent in FY 2024–25, marking the ...
Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...
DJUSD is facing a potential 1,000-student decline over the next 10 years due to lower birth rates and high housing costs, and ...
Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties. See why OMER is a Buy.
The Healthcare Innovation Summit Africa (HISA) 2025 has an exceptional Speakers lineup for their event taking place on 22-23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results